A Vincent1, C McAlister, C Vandenhoven, E Héon. 1. Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Abstract
PURPOSE: To describe the spectrum of phenotypic characteristics of BEST1-related autosomal dominant vitreoretinochoroidopathy (ADVIRC) in a family with p.V86M mutation. METHODS: A retrospective review of the clinical, psychophysical, and electrophysiological phenotypes of six subjects with ADVIRC. Five family members were sequenced for mutations in the BEST1 gene. RESULTS: A heterozygous change, p.V86M (c.256G > A), was identified in the BEST1 gene in the three affected subjects tested, and was shown to segregate with the disease phenotype. The distance visual acuity ranged from ≥ 20/25 to absent perception of light. Clinical features observed included angle closure glaucoma (n = 2), microcornea with shallow anterior chamber (n = 1), iris dysgenesis (n = 2), cataracts (n = 4), classical peripheral concentric band of retinal hyperpigmentation (n = 5), and optic nerve dysplasia (n = 1). Full-field electroretinogram response amplitudes ranged from low normal (two cases; 27 and 32 years) to non-recordable (two cases; 42 and 63 years). Goldmann fields were normal in two (27 and 28 years) but were abnormal in two older subjects. Optical coherence tomography showed macular thinning in the proband, whereas his affected daughter had normal macular thickness. Electro-oculography showed borderline Arden's ratio (1.50) in the lone case tested (27 years). CONCLUSION: ADVIRC is a slowly progressive vitreoretinal degeneration that demonstrates marked intra-familial phenotypic variability. Optic nerve dysplasia and iris dysgenesis are novel observations that extend the ocular phenotype of ADVIRC.
PURPOSE: To describe the spectrum of phenotypic characteristics of BEST1-related autosomal dominant vitreoretinochoroidopathy (ADVIRC) in a family with p.V86M mutation. METHODS: A retrospective review of the clinical, psychophysical, and electrophysiological phenotypes of six subjects with ADVIRC. Five family members were sequenced for mutations in the BEST1 gene. RESULTS: A heterozygous change, p.V86M (c.256G > A), was identified in the BEST1 gene in the three affected subjects tested, and was shown to segregate with the disease phenotype. The distance visual acuity ranged from ≥ 20/25 to absent perception of light. Clinical features observed included angle closure glaucoma (n = 2), microcornea with shallow anterior chamber (n = 1), iris dysgenesis (n = 2), cataracts (n = 4), classical peripheral concentric band of retinal hyperpigmentation (n = 5), and optic nerve dysplasia (n = 1). Full-field electroretinogram response amplitudes ranged from low normal (two cases; 27 and 32 years) to non-recordable (two cases; 42 and 63 years). Goldmann fields were normal in two (27 and 28 years) but were abnormal in two older subjects. Optical coherence tomography showed macular thinning in the proband, whereas his affected daughter had normal macular thickness. Electro-oculography showed borderline Arden's ratio (1.50) in the lone case tested (27 years). CONCLUSION: ADVIRC is a slowly progressive vitreoretinal degeneration that demonstrates marked intra-familial phenotypic variability. Optic nerve dysplasia and iris dysgenesis are novel observations that extend the ocular phenotype of ADVIRC.
Authors: Agnes B Renner; Hilmar Tillack; Hannelore Kraus; Franziska Krämer; Nicole Mohr; Bernhard H F Weber; Michael H Foerster; Ulrich Kellner Journal: Ophthalmology Date: 2005-04 Impact factor: 12.079
Authors: Agnes B Renner; Hilmar Tillack; Hannelore Kraus; Susanne Kohl; Bernd Wissinger; Nicole Mohr; Bernhard H F Weber; Ulrich Kellner; Michael H Foerster Journal: Retina Date: 2004-12 Impact factor: 4.256
Authors: R Burgess; R E MacLaren; A E Davidson; J E Urquhart; G E Holder; A G Robson; A T Moore; R O' Keefe; G C M Black; F D C Manson Journal: J Med Genet Date: 2008-07-08 Impact factor: 6.318
Authors: Rosemary Burgess; Ian D Millar; Bart P Leroy; Jill E Urquhart; Ian M Fearon; Elfrida De Baere; Peter D Brown; Anthony G Robson; Genevieve A Wright; Philippe Kestelyn; Graham E Holder; Andrew R Webster; Forbes D C Manson; Graeme C M Black Journal: Am J Hum Genet Date: 2008-01 Impact factor: 11.025
Authors: Lihua Y Marmorstein; Jiang Wu; Precious McLaughlin; John Yocom; Mike O Karl; Rudgar Neussert; Soenke Wimmers; J Brett Stanton; Ronald G Gregg; Olaf Strauss; Neal S Peachey; Alan D Marmorstein Journal: J Gen Physiol Date: 2006-05 Impact factor: 4.086
Authors: Sancy Low; Alice E Davidson; Graham E Holder; Chris R Hogg; Shomi S Bhattacharya; Graeme C Black; Paul J Foster; Andrew R Webster Journal: Mol Vis Date: 2011-08-23 Impact factor: 2.367
Authors: Anna-Lena Nachtigal; Andrea Milenkovic; Caroline Brandl; Heidi L Schulz; Lisa M J Duerr; Gabriele E Lang; Charlotte Reiff; Philipp Herrmann; Ulrich Kellner; Bernhard H F Weber Journal: Int J Mol Sci Date: 2020-02-26 Impact factor: 5.923
Authors: Morton F Goldberg; Scott McLeod; Mark Tso; Kirk Packo; Malia Edwards; Imran A Bhutto; Rajkumar Baldeosingh; Charles Eberhart; Bernhard H F Weber; Gerard A Lutty Journal: Ophthalmol Retina Date: 2018-04